Sponsor Dossier
iNova Pharmaceuticals
Sponsor Dossier for iNova Pharmaceuticals. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: Acupan
- Brand: AIROMIR
- Brand: ALDARA
- Brand: ALU-TAB
- Brand: Andolex-C Oral
- Brand: BETADINE
- Brand: Burnaid
- Brand: CAL
- Device (sponsor): Nasal irrigation saline solution, non-sterile
- Device (sponsor): Non-sterile scar management dressing, reusable
- Device (sponsor): Irrigation fluid, nasal
- Device (sponsor): Artificial saliva
- Device (sponsor): Adhesive strip, skin-cover
- Device (sponsor): Adhesive strip, skin-cover
About iNova
Pharmaceuticals is an Australian Private Company with ABN 13 617 871 539, registered in NSW and currently active.
Portfolio
iNova Pharmaceuticals has 67 brands on the ARTG, of which 31 are indexable and 27 carry a Product Information document. 21 brands are PBS-listed, 1 has a PBAC outcome on record, and 0 have an AusPAR on record. Notable brands include Acupan, AIROMIR, ALDARA, ALU-TAB, Andolex-C Oral, BETADINE, Burnaid, CAL, CASTOR, CEPACAINE, CEPACOL, ClindaTech.
Therapeutic focus
— Dermatology: 16 brands — Complementary Medicine: 9 brands — Pain Management: 8 brands — Respiratory: 7 brands — Infectious Disease: 6 brands — Gastroenterology: 5 brands — Endocrinology: 4 brands — Cardiology: 3 brands — Musculoskeletal: 2 brands — Immunology: 2 brands — Neurology: 2 brands — Reproductive Health: 1 brand — Other: 1 brand — Psychiatry: 1 brand
PBS footprint
21 brands are PBS-listed, with the latest PBS schedule date 2026-11-01.
Regulatory activity
The latest PBAC outcome is 2009-03-01, across 1 brand with a PBAC outcome on record.